99% High Purity Product Discreet and Secure Shipping Certified Products For research purposes only
Better formulations & clinical access : safer compounding, smarter dosing protocols, and oversight from clinics like ours mean peptides are more practical and safer for patients than they were a decade ago
Headaches have been reported, though distinguishing these from coincidental occurrences proves difficult
Recently, two compoundsAOD 9604 and tirzepatidehave gained attention for their potential roles in supporting weight loss
Safety, Side Effects and Regulatory Status in the UK The safety profile of peptides used for erectile dysfunction is poorly characterised, and their regulatory status in the UK is clear: none of the commonly discussed peptides for ED are licensed by the MHRA for this indication
Despite its promising applications, AOD-9604 remains unapproved by the FDA for weight loss or clinical use